Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 29 for “"Cardiovascular toxicity"”.

  1. The cardiovascular toxicity of antimalarial drugs

    … drug reaction of repolarisation-related cardiotoxicity as sudden deaths, ventricular tachyarrhythmias, and electrocardiographic QT interval prolongation were in turn causally associated with their use. With increasing population-level use of antimalarials for malaria elimination, there has been …

    oxford Repository record for The cardiovascular toxicity of antimalarial drugs (opens in a new tab)

  2. Cardiovascular Toxicity Induced by Fumonisin in Pigs and Horses

    … main purpose of these studies was to examine the cardiovascular effects of fumonisin toxicity in pigs and horses. The overall goal of the research was to expand our knowledge of fumonisin toxicity, and determine the pathophysiological mechanism of fumonisin-induced porcine pulmonary edema and …

    uiuc Repository record for Cardiovascular Toxicity Induced by Fumonisin in Pigs and Horses (opens in a new tab)

  3. Mechanistic Insights and Therapeutic Approaches for Chemotherapy-Induced Cardiovascular Toxicity

    … and oncology to understand and mitigate cardiovascular complications induced by cancer treatment. As cancer survivorship continues to improve globally, the burden of treatment-related cardiovascular complications has emerged as a defining challenge. Several cancer therapies cause …

    umn Repository record for Mechanistic Insights and Therapeutic Approaches for Chemotherapy-Induced Cardiovascular Toxicity (opens in a new tab)

  4. Insights into cardiovascular toxicity of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in breast cancer patients

    … well-characterized QTc prolongation, potential cardiovascular toxicities (CVT) of ribociclib-based combos remain inadequately characterized. Aim of the study: In the present single-center, prospective, observational study, we aimed to evaluate both the incidence and spectrum of …

    greece Repository record for Insights into cardiovascular toxicity of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in breast cancer patients (opens in a new tab)

  5. Improving the Early Detection of Cardiovascular Toxicity Secondary to Radiotherapy for Lung Cancer via Patient-specific Quantitative Magnetic Resonance Imaging

    … In regards to RT-induced cardiac/aortic toxicity, global metrics did not show any significant changes post-RT except for T2/LGE. Though, regional metrics showed significant changes over at least one follow-up with a dose-dependency response among radiobiological metrics. A correlation was …

    vcu Repository record for Improving the Early Detection of Cardiovascular Toxicity Secondary to Radiotherapy for Lung Cancer via Patient-specific Quantitative Magnetic Resonance Imaging (opens in a new tab)

  6. ΣΥΜΒΟΛΗ ΣΤΗ ΜΕΛΕΤΗ ΤΩΝ ΚΑΡΔΙΑΓΓΕΙΑΚΩΝ ΜΕΤΑΒΟΛΩΝ ΜΕΤΑ ΑΠΟ ΕΝΔΟΣΥΝΔΕΣΜΙΚΗ ΑΝΑΙΣΘΗΣΙΑ ΜΕ ΣΥΡΙΓΓΑ ΠΙΕΣΕΩΣ

    … RECORDING AND STATISTICAL EVALUATION OF THE CARDIOVASCULAR CHANGES THAT OCCURED AFTER INTRAVENOUS INTRALIGAMENTAL AND SUBMUCOSAL INJECTIONS OF A CONSTANT QUANTITY OF VARIOUS TYPES OF ANAESTHETIC SOLUTIONS IN WHITE QUINEA PIGS USING A PERI-PRESS SYRINGE. THE PURPOSEOF THIS INVESTIGATION WAS TO …

    greece Repository record for ΣΥΜΒΟΛΗ ΣΤΗ ΜΕΛΕΤΗ ΤΩΝ ΚΑΡΔΙΑΓΓΕΙΑΚΩΝ ΜΕΤΑΒΟΛΩΝ ΜΕΤΑ ΑΠΟ ΕΝΔΟΣΥΝΔΕΣΜΙΚΗ ΑΝΑΙΣΘΗΣΙΑ ΜΕ ΣΥΡΙΓΓΑ ΠΙΕΣΕΩΣ (opens in a new tab)

  7. Evidence Based Assessment of the Cardiovascular Adverse Effects of Specific Cyclooxy-Genase-2 Inhibitors

    … the meta analysis and systematic reviews of the cardiovascular and related safety of rofecoxib for its licensed long-term indications. Method : Systematically search Pubmed, Cochrane, FDA, NICE, EULAR, CCOHTA, to identify systematic reviews concerning rofecoxib’s cardiovascular toxicity. The …

    aston Repository record for Evidence Based Assessment of the Cardiovascular Adverse Effects of Specific Cyclooxy-Genase-2 Inhibitors (opens in a new tab) Download PDF for Evidence Based Assessment of the Cardiovascular Adverse Effects of Specific Cyclooxy-Genase-2 Inhibitors (opens in a new tab)

  8. Ο ρόλος της αναστολής του πρωτεασώματος στη λειτουργία των αγγείων και στην αθηρωμάτωση σε ανθρώπους

    … multiple myeloma (RRMM) but is associated with cardiovascular adverse events (CVAE). Although experimental data suggest that CFZ associated cardiovascular toxicity is exerted at least in part through endothelial dysfunction, the clinical relevance of the latter as a toxicity biomarker in CFZ …

    greece Repository record for Ο ρόλος της αναστολής του πρωτεασώματος στη λειτουργία των αγγείων και στην αθηρωμάτωση σε ανθρώπους (opens in a new tab)

  9. Diethylstilbestrol Nanosuspensions for Prostate Cancer: Subcutaneous Sustained Release Formulations and Pre-clinical PK/PD Evaluations

    … was drastically reduced because of its severe cardiovascular toxicity and thromboembolic complications such as deep vein thrombosis, pulmonary embolism and heart attack. At the same time, luteinizing hormone releasing hormone (LHRH) agonists were found to have similar efficacy profile to that …

    houston Repository record for Diethylstilbestrol Nanosuspensions for Prostate Cancer: Subcutaneous Sustained Release Formulations and Pre-clinical PK/PD Evaluations (opens in a new tab)

  10. Structure-Activity Relationship (SAR) of Novel Antibiotics Targeting LpxH and LpxC in Lipid A Biosynthesis

    … current efforts have been hindered by unexpected cardiovascular toxicity in vivo. Herein, we report the preclinical characterization of a novel LpxC inhibitor that has slow, tight binding, low pM affinity, oral bioavailability, and an exceptional in vivo safety profile. Additionally, accumulating …

    duke Repository record for Structure-Activity Relationship (SAR) of Novel Antibiotics Targeting LpxH and LpxC in Lipid A Biosynthesis (opens in a new tab)

  11. ΑΝΑΛΥΣΗ ΤΩΝ ΑΛΛΗΛΕΠΙΔΡΑΣΕΩΝ ΑΝΘΡΑΚΥΚΛΙΝΩΝ-ΣΙΔΗΡΟΠΟΡΦΥΡΙΝΩΝ ΣΤΟ ΑΙΜΟΠΟΙΗΤΙΚΟ ΣΥΣΤΗΜΑ

    … DUE TO THEIR BONE MARROW (MYELOSUPPRESSION) AND CARDIOVASCULAR TOXICITY. UNFORTUNATELY, IT HASN'T BEEN A UNIFIED THEORY TO EXPLAIN THE PLEOTROPIC EFFECTS OF ADR ON SEVERAL TISSUES. THE OBSERVATIONS THAT HEMIN (IRON-PROTOPORPHYRIN IX) COUNTERACTS ADR-INDUCED CYTOTOXICITY SELECTIVELY IN NORMAL AND …

    greece Repository record for ΑΝΑΛΥΣΗ ΤΩΝ ΑΛΛΗΛΕΠΙΔΡΑΣΕΩΝ ΑΝΘΡΑΚΥΚΛΙΝΩΝ-ΣΙΔΗΡΟΠΟΡΦΥΡΙΝΩΝ ΣΤΟ ΑΙΜΟΠΟΙΗΤΙΚΟ ΣΥΣΤΗΜΑ (opens in a new tab)

  12. Detecting subclinical anthracycline therapy related cardiac dysfunction in low income country (SATRACD study)

    … (ATRCD) is the most common chemotherapy-induced cardiovascular toxicity. It begins with subclinical myocardial cell injury that can be detected using speckle tracking echocardiography (STE), together with Troponin-I. Limited availability of STE in Uganda posts challenges in detecting subclinical …

    cape-town Repository record for Detecting subclinical anthracycline therapy related cardiac dysfunction in low income country (SATRACD study) (opens in a new tab)

  13. Modelling adverse drug reactions using induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs)

    … and their incidence is steadily increasing. Cardiovascular toxicity is one of the most common and serious ADR and is the leading cause of drug discontinuation. The overarching goal of this thesis is to investigate cardiac ADRs using human pluripotent stem cell derived cardiomyocytes …

    ubc Repository record for Modelling adverse drug reactions using induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) (opens in a new tab) Download PDF for Modelling adverse drug reactions using induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) (opens in a new tab)

  14. Non steroidal anti-inflammatory drugs and cardiovascular risk: identifying evidence for channelling bias in a population based study

    … has been associated with a high risk for cardiovascular events in observational studies. However, majority of studies identifying this association were conducted when diclofenac was the only NSAID that could be obtained as a combination product (i.e., formulated with misoprostol). As a …

    sask Repository record for Non steroidal anti-inflammatory drugs and cardiovascular risk: identifying evidence for channelling bias in a population based study (opens in a new tab)

  15. G-Protein-Coupled Estrogen Receptor-1 (GPER): A Potential Target For Xenoestrogens During Vertebrate Embryogenesis.

    … G-1-induced teratogenesis, suggesting that G-1 toxicity is mediated via aberrant GPER activation. Based on these data, we hypothesized that the developing cardiovascular system was the primary target organ for G-1-induced toxicity. Using quantitative in vivo imaging assays and transgenic …

    south-carolina Repository record for G-Protein-Coupled Estrogen Receptor-1 (GPER): A Potential Target For Xenoestrogens During Vertebrate Embryogenesis. (opens in a new tab)

  16. Fibrin clot structure alterations after particulate matter exposure

    … has been associated with increased risks of cardiovascular diseases. Fibrin clot structure alteration is an emerging risk factor of many cardiovascular diseases, especially thrombosis. Therefore, the aim of this study was to investigate whether and how air particulate matter affects fibrin …

    whiterose Download PDF for Fibrin clot structure alterations after particulate matter exposure (opens in a new tab)

  17. Identification of genetic factors predisposing to chemotherapy and immunotherapy toxicity

    … of life. The ability to predict patients’ toxicity risk from systemic anti-cancer therapy can help personalise treatment. Germline genetic variation has been shown to be a key determinant of toxicity risk. My thesis aimed to identify genetic variants predisposing towards chemotherapy and …

    birmingham Download PDF for Identification of genetic factors predisposing to chemotherapy and immunotherapy toxicity (opens in a new tab)

  18. The antidepressant properties of selected methylene blue analogues

    … MAO inhibition is also responsible for cardiovascular toxicity in clinically used MAOI inhibitors. For this purpose we investigated the antidepressant properties of the synthetic MB analogue (ethyl-thioniniumchloride; ETC) as well as azure B, the major metabolite of MB, in the forced …

    nwu-za Repository record for The antidepressant properties of selected methylene blue analogues (opens in a new tab)

  19. Intratracheal instillation of silver nanoparticles exacerbates cardiac ischemia/reperfusion injury in male sprague-dawley rats

    … has been demonstrated to negatively influence cardiovascular health and expand myocardial infarction. Furthermore, pulmonary exposure to various engineered nanomaterials has, likewise, demonstrated the ability to exacerbate cardiac ischemia reperfusion (I/R) injury. We hypothesized that …

    ecu Repository record for Intratracheal instillation of silver nanoparticles exacerbates cardiac ischemia/reperfusion injury in male sprague-dawley rats (opens in a new tab)

  20. Pharmacokinetic Studies of Enteric and Delayed Release Formulations of Locally Bioavailable Drugs (LBD) Targeting the Colon

    … effective against FAP. On-target off-organ cardiovascular toxicity prevents the use of Celecoxib as a treatment for FAP. A new selective COX-2 inhibitor, 6A1, is less systemically bioavailable due to its ability to undergo enterohepatic recycling (EHR). EHR delivered a variable quantity of …

    houston Repository record for Pharmacokinetic Studies of Enteric and Delayed Release Formulations of Locally Bioavailable Drugs (LBD) Targeting the Colon (opens in a new tab)

Page 1 of 2